JP2024096899A5 - - Google Patents

Download PDF

Info

Publication number
JP2024096899A5
JP2024096899A5 JP2024065962A JP2024065962A JP2024096899A5 JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5 JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5
Authority
JP
Japan
Prior art keywords
cell
cells
nucleic acid
acid encoding
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024065962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024096899A (ja
JP7817708B2 (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/027697 external-priority patent/WO2020013315A1/ja
Application filed filed Critical
Publication of JP2024096899A publication Critical patent/JP2024096899A/ja
Publication of JP2024096899A5 publication Critical patent/JP2024096899A5/ja
Priority to JP2025182692A priority Critical patent/JP2026021431A/ja
Application granted granted Critical
Publication of JP7817708B2 publication Critical patent/JP7817708B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024065962A 2018-07-13 2024-04-16 γδT細胞の製造方法 Active JP7817708B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025182692A JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2018133727 2018-07-13
JP2018133727 2018-07-13
JP2019117891 2019-06-25
JP2019117891 2019-06-25
PCT/JP2019/027697 WO2020013315A1 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法
JP2020530276A JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020530276A Division JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025182692A Division JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Publications (3)

Publication Number Publication Date
JP2024096899A JP2024096899A (ja) 2024-07-17
JP2024096899A5 true JP2024096899A5 (https=) 2024-11-01
JP7817708B2 JP7817708B2 (ja) 2026-02-19

Family

ID=69143058

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法
JP2024065962A Active JP7817708B2 (ja) 2018-07-13 2024-04-16 γδT細胞の製造方法
JP2025182692A Pending JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025182692A Pending JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Country Status (14)

Country Link
US (2) US12391739B2 (https=)
EP (1) EP3822342A4 (https=)
JP (3) JP7479635B2 (https=)
KR (1) KR20210030373A (https=)
CN (1) CN112513256A (https=)
AU (1) AU2019302207B2 (https=)
BR (1) BR112021000437A2 (https=)
CA (1) CA3106089A1 (https=)
CO (1) CO2021001064A2 (https=)
IL (1) IL280041A (https=)
MX (1) MX2021000459A (https=)
SG (1) SG11202100260QA (https=)
TW (1) TW202020145A (https=)
WO (1) WO2020013315A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
MX2021000459A (es) * 2018-07-13 2021-06-23 Univ Kyoto Metodo para producir celulas t gamma y delta.
CN109337870B (zh) 2018-12-24 2020-07-03 广东暨德康民生物科技有限责任公司 人Vγ9Vδ2T细胞扩增方法与培养基
MX2022006725A (es) * 2019-12-06 2022-08-22 Fate Therapeutics Inc Mejora de célula inmunitaria efectora derivada de ipsc mediante el uso de compuestos pequeños.
WO2021256522A1 (ja) 2020-06-17 2021-12-23 国立大学法人京都大学 キメラ抗原受容体発現免疫担当細胞
KR20230128324A (ko) * 2021-02-05 2023-09-04 고쿠리츠다이가쿠호진 고베다이가쿠 인공 다능성 줄기 세포 유래 γδ T 세포 및 그 제작방법
MX2023011927A (es) * 2021-04-07 2023-10-23 Century Therapeutics Inc Composiciones y metodos para la generacion de linfocitos t gamma-delta a partir de celulas madre pluripotentes inducidas.
CN113583955A (zh) * 2021-08-24 2021-11-02 羽铂精制生物技术(成都)有限公司 一种因子法扩增t细胞的培养基及培养方法
US20230124097A1 (en) * 2021-10-14 2023-04-20 Appia Bio, Inc. Engineering stem cell t cells with multiple t cell receptors
KR20240101640A (ko) * 2021-11-12 2024-07-02 얀센 바이오테크 인코포레이티드 면역 세포의 향상된 확장 및 사용을 위한 재료 및 방법
EP4474476A4 (en) 2022-02-04 2026-02-18 Univ Kyoto T-LYMPHOCYTE PRODUCTION PROCESS
WO2023194911A1 (en) * 2022-04-04 2023-10-12 Gammadelta Therapeutics Ltd Cells expressing an anti-mesothelin car
WO2023194915A1 (en) * 2022-04-04 2023-10-12 Gammadelta Therapeutics Ltd Novel gene armoring
CN118931834B (zh) * 2024-03-07 2025-09-16 珠海善行免疫微生态产业研究院有限公司 一种人Vγ9Vδ2T细胞扩增培养基及其扩增培养方法
CN119530215A (zh) * 2024-11-27 2025-02-28 珠海医米诺赛医学检验有限公司 一种血液处理液及利用该处理液进行染色体核型分析的方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
ATE449162T1 (de) 2000-04-03 2009-12-15 Therapure Biopharma Inc Herstellung von tcr gamma delta t-zellen
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
JPWO2006006720A1 (ja) 2004-07-13 2008-05-01 株式会社メディネット γδT細胞の培養方法、γδT細胞及び治療・予防剤
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
US9051391B2 (en) 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
AU2008297011B2 (en) 2007-08-31 2014-06-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
US20100330063A1 (en) 2007-12-17 2010-12-30 Gliamed, Inc. Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
US20110014164A1 (en) 2008-02-15 2011-01-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
SG188904A1 (en) 2008-03-17 2013-04-30 Scripps Research Inst Combined chemical and genetic approaches for generation of induced pluripotent stem cells
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
AU2009234424A1 (en) 2008-04-07 2009-10-15 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an HDAC modulator
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
JP4281071B1 (ja) * 2008-07-10 2009-06-17 学校法人兵庫医科大学 Vγ9Vδ2T細胞の増殖剤、活性化Vγ9Vδ2T細胞の製造方法およびこれらの利用
EP2313494A2 (en) 2008-07-14 2011-04-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/arid3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
WO2010033906A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
WO2010050626A1 (en) 2008-10-30 2010-05-06 Kyoto University Method for producing induced pluripotent stem cells
WO2010056831A2 (en) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
US9045737B2 (en) 2008-12-13 2015-06-02 Dnamicroarray, Inc. Artificial three-dimensional microenvironment niche culture
JP5553289B2 (ja) 2009-02-27 2014-07-16 国立大学法人京都大学 新規核初期化物質
WO2010102267A2 (en) 2009-03-06 2010-09-10 Ipierian, Inc. Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111422A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US8852940B2 (en) 2009-04-01 2014-10-07 The Regents Of The University Of California Embryonic stem cell specific microRNAs promote induced pluripotency
US20110088107A1 (en) 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
DK2438160T3 (en) 2009-06-05 2016-01-11 Cellular Dynamics Int Inc Reprogramming of T cells and hematopoietic cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
US9206394B2 (en) * 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
CN104053769A (zh) 2011-11-21 2014-09-17 大学健康网络 造血祖细胞群体和富集其干细胞的方法
AU2014248119B2 (en) 2013-04-03 2019-06-20 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted T-cells derived from pluripotent stem cells
KR102654784B1 (ko) * 2014-07-18 2024-04-04 사이아스 가부시키가이샤 다능성 줄기세포로부터 세포-기반 면역요법용 t 세포를 유도하는 방법
WO2016010155A1 (ja) 2014-07-18 2016-01-21 宏 河本 抗原特異的t細胞受容体遺伝子を有する多能性幹細胞の製造方法
AU2015343013B2 (en) 2014-11-05 2020-07-16 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
EP3219791A4 (en) 2014-11-13 2018-07-18 Kyoto University Method for induction of t cells from pluripotent stem cells
GB201421716D0 (en) 2014-12-05 2015-01-21 King S College London Cell expansion procedure
EP4295914A3 (en) 2015-09-03 2024-04-10 The UAB Research Foundation Genetically-engineered drug resistant t cells and methods of using the same
JP7017008B2 (ja) * 2015-10-15 2022-02-08 国立大学法人京都大学 多能性幹細胞からcd4陽性t細胞を製造する方法
MX2018005274A (es) 2015-10-30 2019-09-19 The Regents Of The Universtiy Of California Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
ES2886631T3 (es) * 2016-04-15 2021-12-20 Univ Kyoto Método para inducir células T positivas para CD8 específicas de antígeno
EP3476934A4 (en) * 2016-06-23 2020-02-26 Kyoto University METHOD FOR PRODUCING CD4 / CD8 POSITIVE DUAL T CELLS
EP3572502B1 (en) 2017-01-20 2023-01-11 Kyoto University Method for producing cd8alpha +beta + cytotoxic t cells
WO2018143243A1 (ja) 2017-02-03 2018-08-09 国立大学法人神戸大学 人工多能性幹細胞の作製方法
WO2018147801A1 (en) 2017-02-07 2018-08-16 Agency For Science, Technology And Research Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
JP2018133727A (ja) 2017-02-16 2018-08-23 富士通株式会社 無線通信システム、無線通信装置、及びビームパターン決定方法
EP3597734A4 (en) * 2017-03-14 2021-03-03 Kyoto University METHOD FOR PRODUCING HELPER T-CELLS FROM PLURIPOTENT STEM CELLS
JP7109916B2 (ja) 2017-12-27 2022-08-01 株式会社ディスコ 分割装置
MX2021000459A (es) 2018-07-13 2021-06-23 Univ Kyoto Metodo para producir celulas t gamma y delta.
EP3831936A4 (en) * 2018-07-31 2022-04-13 Thyas Co. Ltd. METHOD FOR PRODUCING A REGENERATED T LYMPHOCYTE POPULATION USING IPS CELLS
JP7723935B2 (ja) * 2019-11-01 2025-08-15 国立大学法人京都大学 T細胞の製造方法
AU2020393334A1 (en) * 2019-11-25 2022-06-16 Kyoto University T-cell master cell bank
WO2022059780A1 (ja) * 2020-09-18 2022-03-24 サイアス株式会社 iPS細胞を介する再生T細胞の製造方法
CA3193384A1 (en) * 2020-09-24 2022-03-31 Hiroshi Kawamoto Method for preparing effector cells with desired specificity
JPWO2022145490A1 (https=) * 2021-01-04 2022-07-07

Similar Documents

Publication Publication Date Title
JP2024096899A5 (https=)
JP2026021431A5 (https=)
JP2021520849A5 (https=)
JP2023055884A5 (https=)
CN109735497A (zh) 一种提高胎儿血红蛋白表达水平的方法
JP2020511131A5 (https=)
JP2003527856A5 (https=)
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
WO2004101756A3 (en) Ovr110 antibody compositions and methods of use
JP2021528096A5 (https=)
JP2021525519A5 (https=)
JPWO2020150478A5 (https=)
JPWO2021136263A5 (https=)
JPWO2022051749A5 (https=)
Stévenin et al. Relationship between nuclear giant-size dRNA and microsomal dRNA of rat brain
MX2024013891A (es) Vacunas y métodos para usarlas para tratar cáncer relacionado con wnt
JPWO2020002540A5 (https=)
JP2007509063A5 (https=)
JP2019508056A5 (https=)
WO2024178397A3 (en) Modified immune effector cells and methods of use
JPWO2020198587A5 (https=)
WO2021263097A3 (en) Methods and compositions for treating multiple sclerosis
JPWO2023010073A5 (https=)
JPWO2022094348A5 (https=)
JPWO2021113558A5 (https=)